P remature ventricular contractions (PVCs) can deteriorate heart failure status and increase appropriate implantable cardioverter defibrillator (ICD) therapies. [1] Epicardial PVC/ ventricular tachycardia (VT) is more common in non-ischemic cardiomyopathy than ischemic cardiomyopathy. [2] Radiofrequency catheter ablation (RFCA) is a curative treatment option for PVC/VT and can improve cardiac function. [3, 4] This report describes the case of a patient with ischemic cardiomyopathy who had multiple appropriate ICD therapies and was treated with RFCA in the anterior interventricular vein and a cardiac resynchronization therapy defibrillator (CRT-D) upgrade in the same procedure.
CASE REPORT
A 60-year-old male was referred to the clinic for frequent PVCs and appropriate ICD shocks. He had a history of congestive heart failure (CHF) (New York Heart Association [NYHA] Class III-IV), coronary artery bypass grafting operation, and a prior DDD-ICD implantation for primary prevention 4 years earlier. He had been doing well until he received 6 ICD shocks in the 3 weeks prior to presentation, and 2 re- cent hospitalizations for episodes of decompensated heart failure. His medications included amiodarone, spironolactone, ramipril, atorvastatin, clopidogrel, and carvedilol. He had undergone 2 failed electroanatomic endocardial ablation attempts at another clinic 6 months earlier, during which the surgeons reportedly could not achieve successful endocardial ablation and could not pass distal to the great cardiac vein (GCV) due to a well-developed Vieussens valve.
Transthoracic echocardiography revealed depressed left ventricle (LV) systolic function (LV ejection fraction: 10%). An electrocardiogram (ECG) revealed nonspecific intraventricular conduction delay (QRSd=140 milliseconds) and frequent PVCs/couplets exhibiting a right bundle branch block and inferior axis QRS morphology. The PVCs had a pseudodelta wave, and the precordial maximum deflection index was 0.70 milliseconds (>0.55 milliseconds), which suggested epicardial origin (Figure 1a ). There were 24,200 (23%) single PVCs and 1118 couplets on the 24-hour Holter ECG monitoring report. RFCA treatment of the PVCs through the coronary sinus (CS) and subsequent CRT-D upgrade during the same procedure was planned. 
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CS cannulation was performed with a CS guiding catheter via a left axillary vein puncture. A circumferentially well-developed Vieussens valve was engaged with a telescopic inner catheter and passed with the help of 0.035" hydrophilic guidewire manipulation to the distal part of the CS (Figure 1c) . CS venography was performed to delineate the anterior interventricular vein (AIV) (Figure 1d ). AIV mapping with a 5-F ablation catheter revealed earliest electrical activation at the proximal part of the AIV preceding the QRS onset by -50 milliseconds with good 12/12 pacemapping (Figure 1b ). Ablation at this site for 60 seconds promptly achieved total suppression of PVCs ( Figure 1E and 1f) . No PVC was inducible afterwards by right ventricular burst pacing or programmed electrical stimulation under isoproterenol infusion (2-4 µg/minute). A suitable posterior branch of the CS was cannulated with an inner catheter and a LV pacing lead was implanted to the middle segment of this branch (Figure 2a and b) . The previous DDD-ICD system was replaced with a CRT-D. The post-procedural ECG result is provided in Figure 2c . His clinical status rapidly improved to NYHA Class II during the postoperative period and he was discharged 5 days later. He improved to NYHA I-II with no palpitations and no re-hospitalization. A Holter recording performed at 6-month visit revealed no VT but 345 multiform PVC.
DISCUSSION
RFCA has clinical benefits to patients with PVCs/VT, such as symptomatic relief and improvement of LV function, especially in patients with frequent PVCs in ischemic cardiomyopathy. [3] Recent studies arising from electrophysiology laboratories have demonstrated that systolic dysfunction may improve, and even normalize, after successful ablation of high-burden PVCs (generally >10% PVCs). [5] [6] [7] These data suggest that PVCs could be a significant and modifiable risk factor for incident CHF. PVCs can impair quality of life and sometimes require the long-term use of antiarrhythmic medications, which are often ineffective and may have serious adverse effects. [8] RFCA of ventricular arrhythmias via the GCV-AIV may pose difficulties because of the proximity to coronary arteries and the limited capability of radiofrequency energy due to high impedance. [9] A potential major complication of RFCA delivered to the GCV is coronary artery injury as a result of the close anatomical relationship. [10] Other potential problems are the possibility of catheter entrapment in small branches, limited catheter cooling from the surrounding blood flow, and failure to advance the ablation catheter through the GCV to the AIV, which was the case in this patient. Fifteen percent of patients were found to have a well-developed Vieussens valve after the GCV crossed the circumflex artery. [10] The option of upgrading the CRT-D and postponing ablation of the PVC to another session was dismissed due to possibility of LV lead dislodgement during a subsequent ablation procedure. First, we planned to pass the venous valve and then to ablate the PVCs originating from the AIV. Second, because of the compelling venous valve, we decided to implant the LV lead quickly. In our patient, ventricular arrhythmia causing ICD shocks was idiopathic PVCs arising from the AIV. No endocardial substrate ablation was planned because there was no scar-related ischemic VT. After ablation of the epicardial PVCs, no ventricular arrhythmia was observed. To our knowledge, the present case represents the first case of simultaneous ablation of epicardial PVCs and CRT-D upgrade.
In conclusion, passing the Vieussens valve with the help of a telescopic system was very useful to provide enough catheter support and to demonstrate the Vieussens valve. Therefore, ablation of epicardial PVCs via the CS system and a CRT implantation/upgrade may be a reasonable alternative to a consecutive strategy in a limited number of patients who will eventually require both.
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